KLK3 and posterior cortical atrophy: In these cases, DRE represents a tool that should be used in the clinical evaluation of men with PCa under Active Surveillance (AS) regardless of PSA values, even though DRE alone cannot rule out the presence of clinically significant PCa (csPCa).